X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥815,127.38 +0.10%
以太坊 ¥24,965.96 -0.72%
币安币 ¥5,362.54 -1.06%
Optimism ¥4.64 +1.32%
Arbitrum ¥2.73 +1.59%
Solana ¥1,158.94 -1.57%
Polygon ¥1.56 +2.77%
Cosmos ¥30.37 +2.68%
Avalanche ¥152.80 -0.85%

比特币 ¥815,127.38 +0.10%
以太坊 ¥24,965.96 -0.72%
币安币 ¥5,362.54 -1.06%
Optimism ¥4.64 +1.32%
Arbitrum ¥2.73 +1.59%
Solana ¥1,158.94 -1.57%
Polygon ¥1.56 +2.77%
Cosmos ¥30.37 +2.68%
Avalanche ¥152.80 -0.85%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed